New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export ABBV’s income statement to Excel — free account
AbbVie Inc.
ABBVHealthcare Drug Manufacturers General
AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024.
- Revenue
- +10.3%
- EPS
- +2,270.0%
- Free cash flow
- +9.97%
- Total debt
- +17.7%
Quarter to September 2026, against a year earlier
288.73
5.22
+1.84%
Follow ABBV
Alert me
What it owns vs. what it owes End of fiscal 2025, Dec 31, 2025
It owes $62.2B more in debt than it holds in cash and short-term investments. Debt has risen from $36.8B to $67.5B since FY16. Liabilities are $3.2B more than assets: shareholders’ equity is negative. What is a balance sheet?
Owns
$104.9BLong-term assets
$23.8BOther short-term assets
$5.3BCash & short-term investments
Funded by
$69.7BOther liabilities
$67.5BDebt
Debt is 50.4% of the total; liabilities are $3.2B more than assets.
Net debt has held near 46% of assets since FY16.
Net debt ÷ assets (right axis)
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $66.1B | $70.8B | $59.4B | $89.1B | $150.6B | $146.5B | $138.8B | $134.7B | $135.2B | $134.0B |
| Net debt (debt less cash) | $30.4B | $27.6B | $32.2B | $26.8B | $77.6B | $66.9B | $54.0B | $46.6B | $61.6B | $62.2B |
| Net debt ÷ assets (right axis) | 46.0% | 39.0% | 54.3% | 30.1% | 51.5% | 45.6% | 38.9% | 34.6% | 45.6% | 46.5% |
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
6,423.00 | 9,789.00 | 8,061.00 | 39,924.00 | 8,479.00 | 9,830.00 | 9,229.00 | 12,816.00 | 5,555.00 | 5,257.00 |
Receivables |
4,758.00 | 5,088.00 | 5,384.00 | 5,428.00 | 8,822.00 | 9,977.00 | 11,254.00 | 11,155.00 | 10,919.00 | 12,589.00 |
Inventory |
1,444.00 | 1,605.00 | 1,605.00 | 1,813.00 | 3,310.00 | 3,128.00 | 3,579.00 | 4,099.00 | 4,181.00 | 4,951.00 |
Total current assets |
16,187.00 | 21,223.00 | 16,945.00 | 49,519.00 | 24,173.00 | 27,928.00 | 28,463.00 | 33,002.00 | 25,582.00 | 29,062.00 |
Property, Plant, Equpment (Net) |
2,604.00 | 2,803.00 | 2,883.00 | 2,962.00 | 5,248.00 | 5,110.00 | 4,935.00 | 4,989.00 | 5,134.00 | 5,628.00 |
Long-Term Investments |
1,783.00 | 2,090.00 | 1,420.00 | 93.00 | 293.00 | 277.00 | 241.00 | 304.00 | 279.00 | 268.00 |
Goodwill and Intangible Assets (Total) |
44,313.00 | 43,344.00 | 36,896.00 | 34,253.00 | 116,000.00 | 108,330.00 | 99,595.00 | 87,903.00 | 95,024.00 | 88,281.00 |
Long-term assets (Other) |
1,212.00 | 1,326.00 | 1,208.00 | 2,288.00 | 4,851.00 | 4,884.00 | 5,571.00 | 8,513.00 | 9,142.00 | 10,721.00 |
Total non-current assets |
49,912.00 | 49,563.00 | 42,407.00 | 39,596.00 | 126,392.00 | 118,601.00 | 110,342.00 | 101,709.00 | 109,579.00 | 104,898.00 |
Total Assets |
66,099.00 | 70,786.00 | 59,352.00 | 89,115.00 | 150,565.00 | 146,529.00 | 138,805.00 | 134,711.00 | 135,161.00 | 133,960.00 |
Accounts Payable |
9,379.00 | 10,226.00 | 11,931.00 | 11,832.00 | 20,159.00 | 22,699.00 | 25,402.00 | 30,650.00 | 31,945.00 | 34,734.00 |
Current Part of Debt |
402.00 | 6,415.00 | 5,308.00 | 3,753.00 | 8,502.00 | 12,495.00 | 4,136.00 | 7,191.00 | 6,804.00 | 8,555.00 |
Total current liabilities |
9,781.00 | 16,641.00 | 17,239.00 | 15,585.00 | 28,661.00 | 35,194.00 | 29,538.00 | 37,841.00 | 38,749.00 | 43,289.00 |
Long Term Debt (Total) |
36,440.00 | 30,953.00 | 35,002.00 | 62,975.00 | 77,554.00 | 64,189.00 | 59,135.00 | 52,194.00 | 60,340.00 | 58,941.00 |
Long Term Tax Liability (Deferred) |
6,890.00 | 2,490.00 | 1,067.00 | 1,130.00 | 3,646.00 | 3,009.00 | 2,190.00 | 1,952.00 | 2,579.00 | 2,389.00 |
Non-current Liabilities (Other) |
8,352.00 | 15,605.00 | 14,490.00 | 17,597.00 | 27,607.00 | 28,701.00 | 30,655.00 | 32,327.00 | 30,129.00 | 32,569.00 |
Total non-current liabilities |
51,682.00 | 49,048.00 | 50,559.00 | 81,702.00 | 108,807.00 | 95,899.00 | 91,980.00 | 86,473.00 | 93,048.00 | 93,899.00 |
Total liabilities |
61,463.00 | 65,689.00 | 67,798.00 | 97,287.00 | 137,468.00 | 131,093.00 | 121,518.00 | 124,314.00 | 131,797.00 | 137,188.00 |
Additional Paid In Capital |
13,678.00 | 14,270.00 | 14,756.00 | 15,193.00 | 17,384.00 | 18,305.00 | 19,245.00 | 20,180.00 | 21,333.00 | 22,495.00 |
Common Stock (Net) |
18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 |
Retained Earnings |
4,378.00 | 5,459.00 | 3,368.00 | 4,717.00 | 1,055.00 | 3,127.00 | 4,784.00 | (1,000.00) | (7,900.00) | (15,493.00) |
Treasury Stock |
10,852.00 | 11,923.00 | 24,108.00 | 24,504.00 | 2,264.00 | 3,143.00 | 4,594.00 | 6,533.00 | 8,201.00 | 9,146.00 |
Common Equity (Total) |
4,636.00 | 5,097.00 | (8,446.00) | (8,172.00) | 13,097.00 | 15,436.00 | 17,287.00 | 10,397.00 | 3,364.00 | (3,228.00) |
Shareholders Equity (Total) |
4,636.00 | 5,097.00 | (8,446.00) | (8,172.00) | 13,097.00 | 15,436.00 | 17,287.00 | 10,397.00 | 3,364.00 | (3,228.00) |
Shareholders Equity and Liabilities (Total) |
66,099.00 | 70,786.00 | 59,352.00 | 89,115.00 | 150,565.00 | 146,529.00 | 138,805.00 | 134,711.00 | 135,161.00 | 133,960.00 |
Shares (Common) |
1,592.51 | 1,592.13 | 1,483.90 | 1,478.91 | 1,765.13 | 1,768.34 | 1,769.18 | 1,765.94 | 1,765.26 | 1,767.88 |
Shareholders Equity (Tangible) |
(39,677.00) | (38,247.00) | (45,342.00) | (42,425.00) | (102,903.00) | (92,894.00) | (82,308.00) | (77,506.00) | (91,660.00) | (91,509.00) |
Net Debt |
30,419.00 | 27,579.00 | 32,249.00 | 26,804.00 | 77,577.00 | 66,854.00 | 54,042.00 | 46,569.00 | 61,589.00 | 62,239.00 |
Total Debt |
36,842.00 | 37,368.00 | 40,310.00 | 66,728.00 | 86,056.00 | 76,684.00 | 63,271.00 | 59,385.00 | 67,144.00 | 67,496.00 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026